No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
VTR240816C45000
- 8.70
- 0.000.00%
15min DelayClose Jul 19 16:00 ET
8.70High8.40Low
8.40Open8.70Pre Close2 Volume442 Open Interest45.00Strike Price1.71KTurnover32.41%IV0.75%PremiumAug 16, 2024Expiry Date8.30Intrinsic Value100Multiplier25DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type0.9800Delta0.0106Gamma6.27Leverage Ratio-0.0105Theta0.0308Rho6.14Eff Leverage0.0069Vega
Intraday
- 5D
- Daily
News
Express News | Ventas Inc : BMO Raises Target Price to $60 From $57
Real Estate Stocks Gain as Traders Look for Alternatives to Tech Stocks
(VTR) - Analyzing Ventas's Short Interest
Ventas's (NYSE:VTR) short percent of float has fallen 6.57% since its last report. The company recently reported that it has 7.61 million shares sold short, which is 2.56% of all regular shares that
Ventas Announces Second Quarter 2024 Earnings Release Date and Conference Call
Ventas, Inc. (NYSE:VTR) will issue its second quarter 2024 earnings release after the close of trading on the New York Stock Exchange on Thursday, August 1, 2024. A conference call to discuss those earnings will be held
Ventas Is Maintained at Outperform by Evercore ISI Group
Ventas Is Maintained at Outperform by Evercore ISI
Ventas Price Target Raised to $56.00/Share From $53.00 by Evercore ISI Group
Ventas Price Target Raised to $56.00/Share From $53.00 by Evercore ISI
Comments
Analyst Connor Siversky predicts OHI and NHI's rent coverage will increase due to improving portfolio metrics. However, he doubts VTR's senior housing portfolio improvement will offset high leverage and limited investment opportunities. He also suggests OHI's dividend will be covered in late 2024, and NHI is set to drive growth with a strong liquidity profile.
Omega Healthcare, National Health Investors Upgraded to Overweight at Wells Fargo 1
follow for daily top watchlist ⭐️
$Apyx Medical(APYX.US$ $Addentax(ATXG.US$ $Axsome Therapeutics(AXSM.US$ $BioXcel Therapeutics(BTAI.US$ $Baudax Bio(BXRX.US$ $CymaBay Therapeutics(CBAY.US$ $CorMedix(CRMD.US$ $Marriott International(MAR.US$ $Microvision(MVIS.US$ $Renalytix(RNLX.US$ $State Street(STT.US$ $Treehouse Foods(THS.US$ $Targa Resources(TRGP.US$ $VBI Vaccines(VBIV.US$ $Ventas Inc(VTR.US$
$Apyx Medical(APYX.US$ $Addentax(ATXG.US$ $Axsome Therapeutics(AXSM.US$ $BioXcel Therapeutics(BTAI.US$ $Baudax Bio(BXRX.US$ $CymaBay Therapeutics(CBAY.US$ $CorMedix(CRMD.US$ $Marriott International(MAR.US$ $Microvision(MVIS.US$ $Renalytix(RNLX.US$ $State Street(STT.US$ $Treehouse Foods(THS.US$ $Targa Resources(TRGP.US$ $VBI Vaccines(VBIV.US$ $Ventas Inc(VTR.US$
1
$Affirm Holdings(AFRM.US$ initiated at neutral by Compass Point, announced target price at $15.00.
$SoFi Technologies(SOFI.US$ initiated at sell by Compass Point, announced targe price at $5.00.
$Evotec(EVO.US$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$Principal Financial(PFG.US$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
$SoFi Technologies(SOFI.US$ initiated at sell by Compass Point, announced targe price at $5.00.
$Evotec(EVO.US$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $12.00 to $16.00.
$Principal Financial(PFG.US$ was upgraded by Jefferies from underperform to hold, increased target price from $60.00 to $6...
15
Upgrades
• $Advanced Micro Devices(AMD.US$ : Northland Capital Upgrades to Outperform from Market Perform - PT $95
• $Bunge(BG.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $140)
• $Brookfield Infrastructure Partners LP(BIP.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $49.50
• $Banco Santander Chile(BSAC.US$ : UBS Upgrades to Neutral from Sell - PT $18 (from $17)
• $Crown Castle(CCI.US$ : Jefferi...
• $Advanced Micro Devices(AMD.US$ : Northland Capital Upgrades to Outperform from Market Perform - PT $95
• $Bunge(BG.US$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $140)
• $Brookfield Infrastructure Partners LP(BIP.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $49.50
• $Banco Santander Chile(BSAC.US$ : UBS Upgrades to Neutral from Sell - PT $18 (from $17)
• $Crown Castle(CCI.US$ : Jefferi...
18
2
Read more